Ozempic, Wegovy, Rybelsus Linked to Deadly Stomach Paralysis/Gastroparesis, Other Injuries
Ozempic, (known as Wegovy when prescribed for weight loss) and Rybelsus, popular diabetes drugs also commonly used as a weight loss aid, has come under scrutiny due to claims of severe side effects in users, including gallbladder disease, gallstones, and stomach paralysis, also known as gastroparesis.
Patients who have suffered from these complications may be eligible to pursue legal action against manufacturer Novo Nordisk, on the grounds that the drug maker never warned users about the potential risk of such side effects. If you or someone you love has experienced serious complications from taking Ozempic, it is important to explore your legal options. By seeking legal representation, you can pursue justice for your injuries and potentially receive compensation for the harm you have endured. Contact us today to learn more about the connection between Ozempic and gastroparesis, the potential implications for users, and the process of pursuing a lawsuit against the manufacturer for drug-related injuries.
What is Ozempic?
Ozempic (semaglutide), also called Wegovy, is an FDA-approved medication that entered the market in 2017 and is primarily used to treat Type 2 diabetes but is also commonly prescribed for weight loss.
However, Ozempic has also gained popularity for its off-label use as a weight loss aid. This injectable drug belongs to a class of medications called GLP-1 receptor agonists, which mimic the effects of a hormone released during food consumption. These drugs work by slowing down stomach emptying, leading to reduced calorie absorption and increased feelings of fullness.
While Ozempic has shown positive results for many patients, there have been reports of severe side effects in users. The most recent complaints involving Ozempic have cited a condition called gastroparesis, also known as stomach paralysis. Previously, Ozempic was also linked to acute gallbladder disease side effects, including gallstones.
Link Between Ozempic and Stomach Paralysis
Gastroparesis, or stomach paralysis, is a disorder that affects the normal movement of food from the stomach to the small intestine. It can lead to symptoms such as vomiting, nausea, abdominal bloating, and pain. In some cases, undigested food can harden and form blockages in the intestine, causing further complications.
Gastroparesis can be a debilitating condition, affecting a person’s quality of life and overall well-being. It can lead to nutritional deficiencies, weight loss, and complications related to the digestive system. While the exact link between GLP-1 drugs and gastroparesis is not fully understood, healthcare professionals need to be vigilant in monitoring patients for symptoms such as vomiting, bloating, and early satiety. Prompt recognition and management of gastroparesis can help prevent further complications.
Lawsuits Against Ozempic/Wegovy for Alleged Drug Injuries
"Gastroparesis means paralysis of the stomach. It’s a functional disorder affecting your stomach nerves and muscles. It makes your stomach muscle contractions weaker and slower than they need to be to digest your food and pass it on to your intestines. This leads to food sitting too long in your stomach."
Lawsuits Against Ozempic/Wegovy for Alleged Drug Injuries
When pharmaceutical companies manufacture drugs like Ozempic, they have a responsibility to provide clear and accurate information about potential side effects. In the case of Ozempic, users claim that Novo Nordisk did not sufficiently disclose the risk of severe gastrointestinal events, including gastroparesis. Failure to warn patients about these potential risks can lead to significant harm and may be grounds for legal action. Patients who have experienced severe side effects or complications from taking Ozempic may be eligible to sue the manufacturer, seeking compensation for medical expenses, lost wages, pain and suffering, and other damages resulting from the drug’s alleged adverse effects.
In August 2023, Jaclyn Bjorklund, a 44-year-old woman from Louisiana, became one of the first people to file a lawsuit against Novo Nordisk and Eli Lilly, claiming that the manufacturers failed to adequately warn patients of the potential risks associated with Ozempic and another injectable diabetes drug called Mounjaro. Bjorklund, who experienced “severe gastrointestinal events,” including vomiting, stomach pain, gastrointestinal burning, and teeth loss due to excessive vomiting, alleges in her claim that the drug makers “knew of the association between the use of GLP-1 receptor agonists and the risk of developing severe gastrointestinal issues, including gastroparesis and gastroenteritis,” and that their failure to disclose this information “rendered the warnings for this medication inadequate.”
Call Us Today to Learn How We Can Help
The potential link between Ozempic and severe side effects like gastroparesis or stomach paralysis has raised concerns among patients and healthcare professionals alike. If you or a loved one has experienced stomach paralysis or other severe side effects from taking Ozempic, it is important to take action to protect your rights. By pursuing a drug injury claim against Novo Nordisk, you are not only seeking justice for the harm you have suffered but also holding the drug maker accountable for its actions. Contact us today to discuss your potential claim and determine the best course of action to pursue the compensation you deserve for your injuries.
Did you or a loved one suffer Stomach Paralysis/Gastroparesis or another intestinal injury after use of the Diabetes and Weight Loss Drugs Ozempic, Wegovy or Rybelsus?
Find out now if you qualify for compensation.
Find Out MoreConsumer Safety Watch offers safety advocate services and attorney referral services for patients throughout the United States including the states of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.
Consumer Safety Watch offers consumer safety advocate services or can help you find an attorney throughout the United States including the following cities: Albuquerque, NM; Arlington, TX; Atlanta, GA; Austin, TX; Baltimore, MD; Boston, MA; Charlotte, NC; Chicago, IL; Cleveland, OH; Colorado Springs, CO; Columbus, OH; Dallas, TX; Denver, CO; Detroit, MI; Fresno, CA; Fort Worth, TX; Indianapolis, IN; Honolulu, HI; Houston, TX; Jacksonville, FL; Kansas City, KS; Kansas City, MO; Las Vegas, NV; Long Beach, CA; Los Angeles, CA; Louisville, KY; Memphis, TN; Mesa, AZ; Miami, FL; Miami, OH; Milwaukee, WI; Minneapolis, MN; Nashville, TN; New York City, NY; Oakland, CA; Oklahoma City, OK; Omaha, NE; Philadelphia, PA; Phoenix, AZ; Pittsburgh, PA; Portland, OR; Sacramento, CA; San Antonio, Tx; San Diego, CA; San Francisco, CA; San Jose, CA; Seattle, WA; St. Louis, MO; Tampa, FL; Tucson, AZ; Tulsa, Virginia Beach, VA; Washington, DC; Wichita, KS.
This website is not affiliated with any pharmaceutical or medical device company or any trademarked product. Results are not guaranteed. This website provides a free matching service and is not responsible for information or services from third party providers. Consumer Safety Watch is not a law firm. Every case is different and services available can vary.